(ROOT (S (VP (VB Offer) (NP (DT a) (JJ low-cost) (JJ renin-angiotensin-aldosterone) (NN system) (NN antagonist)) (PP (TO to) (NP (NP (NP (NNS people)) (PP (IN with) (NP (NNP CKD) (CC and) (NNP diabetes)))) (CC and) (NP (NP (DT an) (NNP ACR)) (PP (IN of) (NP (NP (CD 3) (NN mg/mmol)) (CC or) (NP (JJR more) (PRN (-LRB- -LRB-) (NP (NP (NNP ACR) (NN category) (NNP A2)) (CC or) (NP (NNP A3))) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (S (VP (VBG Offer) (NP (DT a) (JJ low-cost) (JJ renin-angiotensin-aldosterone) (NN system) (NN antagonist)) (PP (TO to) (NP (NP (NNS people)) (PP (IN with) (NP (NNP CKD))))))) (CC and) (S (NP (NP (NN hypertension)) (CC and) (NP (NP (DT an) (NNP ACR)) (PP (IN of) (NP (CD 30))))) (VP (VBP mg/mmol) (NP (NP (QP (CC or) (JJR more))) (PRN (-LRB- -LRB-) (NP (NNP ACR) (NNP category) (NNP A3)) (-RRB- -RRB-))))) (. .)))
(ROOT (S (S (VP (VBG Offer) (NP (DT a) (JJ low-cost) (JJ renin-angiotensin-aldosterone) (NN system) (NN antagonist)) (PP (TO to) (NP (NP (NNS people)) (PP (IN with) (NP (NNP CKD))))))) (CC and) (S (NP (NP (DT an) (NNP ACR)) (PP (IN of) (NP (CD 70)))) (VP (VBP mg/mmol) (NP (NP (QP (CC or) (JJR more))) (PRN (-LRB- -LRB-) (NP (NP (NN irrespective)) (PP (IN of) (NP (NP (NN hypertension)) (CC or) (NP (JJ cardiovascular) (NN disease))))) (-RRB- -RRB-))))) (. .)))
(ROOT (FRAG (NP (NP (NNP Control) (NN blood) (NN pressure)) (PP (TO to) (NP (NP (NNS targets)) (PP (IN of) (NP (CD 120-139)))))) (: /) (SINV (VP (VBZ <) (NP (NP (CD 90) (NN mmHg)) (PP (IN in) (NP (NNS people)))) (PP (IN without) (NP (NP (NN diabetes)) (PP (IN with) (NP (NNP ACR) (NNP <)))))) (NP (CD 70) (NN mg/mmol))) (. .)))
(ROOT (S (NP (NP (NNP Control) (NN blood) (NN pressure)) (PP (PP (TO to) (NP (NP (NNS targets)) (PP (IN of) (NP (CD 120-129) (NNS /) (QP (CD <) (CD 80)))) (VP (VBG mmHg) (PP (IN in) (NP (NP (NNS people)) (PP (IN with) (NP (NN diabetes)))))))) (CC or) (PP (IN with) (NP (NNP ACR) (NNP >))))) (VP (SYM =) (NP (CD 70) (NN mg/mmol))) (. .)))
